欧洲甲型H1N1流感病毒对奥司他韦耐药性的出现。 - Suppr

Suppr

超能文献

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

作者信息

Lackenby A, Hungnes O, Dudman S G, Meijer A, Paget W J, Hay A J, Zambon M C

机构信息

Health Protection Agency, Centre for Infection, London, United Kingdom.

出版信息

Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.

DOI:10.2807/ese.13.05.08026-en

PMID:18445375

Abstract

摘要

相似文献

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.欧洲甲型H1N1流感病毒对奥司他韦耐药性的出现。

Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.

Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).对奥司他韦和金刚烷胺耐药的甲型H1N1流感病毒

Emerg Infect Dis. 2009 Jun;15(6):966-8. doi: 10.3201/eid1506.081357.

Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.缅甸季节性流感 A(H1N1)和大流行性流感 A(H1N1)pdm09 病毒出现奥司他韦耐药的时间延迟。

Influenza Other Respir Viruses. 2013 Sep;7(5):766-71. doi: 10.1111/irv.12030. Epub 2012 Nov 5.

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.大洋洲、东南亚和南非地区对奥司他韦耐药的甲型H1N1流感病毒的出现与传播

Antiviral Res. 2009 Jul;83(1):90-3. doi: 10.1016/j.antiviral.2009.03.003. Epub 2009 Mar 24.

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.2007 - 2008年挪威出现的对奥司他韦耐药的甲型H1N1流感病毒

Emerg Infect Dis. 2009 Feb;15(2):155-62. doi: 10.3201/eid1502.081031.

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART.使用一种新的快速检测方法iART监测流感病毒对奥司他韦的敏感性。

Euro Surveill. 2017 May 4;22(18). doi: 10.2807/1560-7917.ES.2017.22.18.30529.

Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.目前在新西兰传播的甲型H1N1流感大流行病毒对奥司他韦敏感。

Euro Surveill. 2009 Jul 30;14(30):19282. doi: 10.2807/ese.14.30.19282-en.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.日本 2008-2009 年季节性流感期间出现 H274Y 耐药的奥司他韦抗甲型 H1N1 流感病毒。

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications.欧洲季节性流感病毒中观察到的奥司他韦耐药性：解读与潜在影响

Euro Surveill. 2008 Jan 31;13(5):8025. doi: 10.2807/ese.13.05.08025-en.

Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.2013 - 2014年中国大陆流感季节期间甲型H1N1pdm09流感病毒对奥司他韦耐药的特征

Virol J. 2015 Jun 24;12:96. doi: 10.1186/s12985-015-0317-1.

引用本文的文献

Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.H274Y 取代对反向遗传流感 A 病毒中 N1、N4、N5 和 N8 神经氨酸酶酶学特性和表达的影响。

Viruses. 2024 Mar 1;16(3):388. doi: 10.3390/v16030388.

Molecular Determinants of Drug Resistance and Mutation Patterns in Influenza Viruses Circulating in Poland Across Multiple Epidemic Seasons: Implications for Vaccination Strategies.波兰多个流行季节流感病毒的耐药性和突变模式的分子决定因素：对疫苗接种策略的影响。

Med Sci Monit. 2024 Mar 6;30:e942125. doi: 10.12659/MSM.942125.

Potential Impact of Environmental Pollution by Human Antivirals on Avian Influenza Virus Evolution.人类抗病毒药物造成的环境污染对禽流感病毒进化的潜在影响。

Animals (Basel). 2023 Mar 23;13(7):1127. doi: 10.3390/ani13071127.

A systemic review on medicinal plants and their bioactive constituents against avian influenza and further confirmation through analysis.关于药用植物及其生物活性成分抗禽流感的系统评价及通过分析进一步确认

Heliyon. 2023 Mar 10;9(3):e14386. doi: 10.1016/j.heliyon.2023.e14386. eCollection 2023 Mar.

Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment.人参皂苷 rk1 通过靶向血凝素 1 介导的病毒附着抑制甲型流感病毒感染的抗病毒作用。

Int J Mol Sci. 2023 Mar 4;24(5):4967. doi: 10.3390/ijms24054967.

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir.静脉注射扎那米韦同情用药成功治疗复杂甲型H3N2流感病毒感染及横纹肌溶解症

Pharmaceuticals (Basel). 2023 Jan 7;16(1):85. doi: 10.3390/ph16010085.

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。

J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.

Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications.用于治疗应用的精密与先进纳米植物药

Nanomaterials (Basel). 2022 Jan 12;12(2):238. doi: 10.3390/nano12020238.

A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors.以H5N1和H1N1神经氨酸酶的催化和非催化位点为查耳酮抑制剂靶点的研究

Appl Biol Chem. 2021;64(1):69. doi: 10.1186/s13765-021-00639-w. Epub 2021 Sep 17.

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.流感聚合酶抑制剂耐药性：现状评估——国际抗病毒研究学会（isirv）抗病毒小组报告。

Antiviral Res. 2021 Oct;194:105158. doi: 10.1016/j.antiviral.2021.105158. Epub 2021 Aug 4.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验